15,661 Shares in Maximus, Inc. (NYSE:MMS) Purchased by Raymond James Financial Inc.

Raymond James Financial Inc. bought a new position in Maximus, Inc. (NYSE:MMS - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 15,661 shares of the health services provider's stock, valued at approximately $1,169,000.

Other hedge funds have also added to or reduced their stakes in the company. UMB Bank n.a. boosted its position in shares of Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after acquiring an additional 158 shares during the period. Eastern Bank bought a new position in Maximus in the 4th quarter valued at $29,000. V Square Quantitative Management LLC grew its position in shares of Maximus by 65.9% during the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after purchasing an additional 180 shares in the last quarter. R Squared Ltd bought a new position in shares of Maximus in the fourth quarter worth $54,000. Finally, IFP Advisors Inc raised its position in shares of Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after buying an additional 302 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company's stock.

Insider Activity at Maximus

In other Maximus news, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the transaction, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. The trade was a 11.88 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now owns 2,512 shares of the company's stock, valued at approximately $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.

Maximus Price Performance

Shares of NYSE:MMS traded up $0.75 during trading on Wednesday, reaching $67.22. The company had a trading volume of 494,672 shares, compared to its average volume of 559,507. The company has a fifty day moving average of $67.69 and a two-hundred day moving average of $73.32. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. The stock has a market capitalization of $3.80 billion, a P/E ratio of 14.46 and a beta of 0.61. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Equities research analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.79%. The ex-dividend date is Thursday, May 15th. Maximus's dividend payout ratio (DPR) is presently 25.81%.

Analysts Set New Price Targets

Separately, StockNews.com lowered Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.